L26/P-526 Establishment of a Fully Integrative Human Endometrial Assembloid Recapitulating the Implantation Window and Supporting In Vitro Implantation
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.859 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von J.L. Welton und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Can a fully integrative human endometrial assembloid recapitulate the receptive implantation window and support human embryo implantation in vitro? Summary answer A multicellular human endometrial assembloid recapitulates hormonal receptivity, immune–vascular remodeling, and supports embryo attachment, invasion, and sustained β-hCG secretion. What is known already Human implantation requires coordinated interactions between luminal epithelium, decidualized stroma, vasculature, and immune cells during a transient window of receptivity. Ethical and technical constraints limit in vivo study of this process, while existing in vitro endometrial models lack full multicellular integration, particularly immune and vascular compartments that are central to implantation success and failure. As a result, mechanistic interrogation of epithelial–stromal–vascular–immune crosstalk and functional implantation outcomes in human systems remains limited, constraining translational research into implantation failure and early pregnancy loss. Study design, size, duration Experimental in vitro study using human endometrial assembloids generated from proliferative-phase biopsies, obtained from multiple independent patients (n = 6). Assembloids were embedded in three-dimensional matrices and hormonally differentiated from proliferative to secretory conditions over an 8-day timeline, with longitudinal assessment of cellular composition, architecture, and function. Implantation competence was evaluated using human blastoids and euploid blastocysts, with co-culture and functional follow-up through 12 days post-fertilization. Participants/materials, setting, methods Human proliferative-phase endometrial biopsies were obtained from premenopausal participants with regular menstrual cycles undergoing benign gynecologic procedures, using defined exclusion criteria. Biopsies were embedded in collagen I/Matrigel and cultured in chemically defined media optimized to support survival of epithelial, stromal, vascular, and immune compartments, with hormonal differentiation induced using estrogen and progesterone/cAMP. Multilineage composition, architecture, and function were assessed by imaging, flow cytometry, ELISA, SEM, and cytokine profiling. Main results and the role of chance Assembloids self-organized into a polarized, apical-out luminal epithelium while maintaining epithelial, stromal, vascular, and immune compartments throughout differentiation. Proportional representation of epithelial, stromal, and vascular populations remained stable over time, with a modest decline in immune abundance by day 8, indicating selective remodeling rather than global loss. Hormonal differentiation induced a receptive phenotype, including increased secretion of IGFBP1, PRL, and PAEP, nuclear translocation of FOXO1, apical enrichment of MUC1, and ultrastructural hallmarks of receptivity such as cilia and pinapodes. Vascular networks persisted long-term with maintained endothelial organization and sustained angiopoietin signaling, reflected by an ANG1/ANG2 ratio consistently >1, supporting vascular stability with dynamic remodeling. Progesterone/cAMP exposure promoted tolerogenic immune adaptation, characterized by reduced cytotoxic CD8+ T cells and CD16+ NK cells, reciprocal increases in CD8^dim and CD56+ NK populations, and attenuation of pro-inflammatory cytokines, compared with estrogen-only conditions, including: IL-6, IL-8, IL-18, TNFα, and IL-1β, while IL-10 levels remained stable and MCP-1 increased over time. Hormonally primed assembloids supported blastoid and blastocyst attachment, trophoblast invasion, interstitial implantation-like events, and sustained β-hCG secretion from euploid embryos throughout the 12 day post-fertilization observation period. Statistical significance was assessed using paired and longitudinal analyses, with reported p-values. Limitations, reasons for caution This study focused on initial validation of the assembloid platform and was not designed to assess later pregnancy outcomes. Future studies will stratify patient-derived assembloids by clinical phenotype, including recurrent implantation failure and recurrent pregnancy loss. Wider implications of the findings This implantation-competent human endometrial assembloid provides a translational platform to study implantation failure and evaluate therapeutic strategies in a human-relevant system. Trial registration number No
Zitieren
APA
Welton, J., Duval, C., & Librach, C. (2026). L26/P-526 Establishment of a Fully Integrative Human Endometrial Assembloid Recapitulating the Implantation Window and Supporting In Vitro Implantation. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.859
Vancouver
Welton J, Duval C, Librach C. L26/P-526 Establishment of a Fully Integrative Human Endometrial Assembloid Recapitulating the Implantation Window and Supporting In Vitro Implantation. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.859
BibTeX
@article{Welton2026,
author = {Welton, J.L. and Duval, C. and Librach, C.},
title = {L26/P-526 Establishment of a Fully Integrative Human Endometrial Assembloid Recapitulating the Implantation Window and Supporting In Vitro Implantation},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.859}
}
EUVIMED